<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="case-report"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cureus</journal-id><journal-id journal-id-type="iso-abbrev">Cureus</journal-id><journal-id journal-id-type="issn">2168-8184</journal-id><journal-title-group><journal-title>Cureus</journal-title></journal-title-group><issn pub-type="epub">2168-8184</issn><publisher><publisher-name>Cureus</publisher-name><publisher-loc>Palo Alto (CA)</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12101477</article-id><article-id pub-id-type="doi">10.7759/cureus.82840</article-id><article-categories><subj-group subj-group-type="heading"><subject>Pathology</subject></subj-group><subj-group><subject>Internal Medicine</subject></subj-group><subj-group><subject>Dermatology</subject></subj-group></article-categories><title-group><article-title>Beyond Ulcerations: A Case of Cutaneous Polyarteritis Nodosa in a Middle-Aged Woman</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Muacevic</surname><given-names>Alexander</given-names></name></contrib><contrib contrib-type="editor"><name><surname>Adler</surname><given-names>John R</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Boughaleb</surname><given-names>Saadia</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Baybay</surname><given-names>Hanane</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Fadlallah</surname><given-names>Imane</given-names></name><xref rid="aff-2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Tahiri Elousrouti</surname><given-names>Layla</given-names></name><xref rid="aff-2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Mernissi</surname><given-names>FatimaZahra</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib></contrib-group><aff id="aff-1">
<label>1</label>
Dermatology, Hassan II University Hospital, Fez, MAR </aff><aff id="aff-2">
<label>2</label>
Pathology, Hassan II University Hospital, Fez, MAR </aff><author-notes><corresp id="cor1">
Saadia Boughaleb <email>boughaleb.saadia@gmail.com</email>
</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>23</day><month>4</month><year>2025</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>4</month><year>2025</year></pub-date><volume>17</volume><issue>4</issue><elocation-id>e82840</elocation-id><history><date date-type="accepted"><day>23</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025, Boughaleb et al.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Boughaleb et al.</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri xlink:href="https://www.cureus.com/articles/361789-beyond-ulcerations-a-case-of-cutaneous-polyarteritis-nodosa-in-a-middle-aged-woman">This article is available from https://www.cureus.com/articles/361789-beyond-ulcerations-a-case-of-cutaneous-polyarteritis-nodosa-in-a-middle-aged-woman</self-uri><abstract><p>Polyarteritis nodosa (PAN) is an immune-mediated necrotizing vasculitis predominantly affecting medium-sized arteries, often manifesting with systemic involvement in its classic form. However, a cutaneous variant (cutaneous polyarteritis nodosa (c-PAN)) confines the disease process to the skin and subcutaneous tissues, typically presenting with painful nodules, chronic ulcerations, and livedo reticularis while sparing major organ systems. Here, we describe a 53-year-old woman with type 2 diabetes and hypertension who developed persistent, painful ulcerative nodules on her lower legs over six months. Laboratory investigations revealed elevated inflammatory markers, negative ANCA, and slightly increased C3. Histopathology confirmed necrotizing arteritis of medium-sized arteries with lobular panniculitis, consistent with c-PAN. She was treated successfully with oral corticosteroids, azathioprine, and supportive wound care, achieving clinical remission without progression to systemic disease. This case underscores the importance of recognizing c-PAN in recalcitrant lower-extremity ulcers and highlights the value of a multidisciplinary approach for optimal patient outcomes.</p></abstract><kwd-group kwd-group-type="author"><kwd>cutaneous polyarteritis nodosa</kwd><kwd>necrotizing vasculitis</kwd><kwd>pathology</kwd><kwd>polyarteritis nodosa</kwd><kwd>systemic vasculitis</kwd><kwd>ulcerated nodules</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Polyarteritis nodosa (PAN) is an immune-mediated necrotizing vasculitis that principally affects medium-sized muscular arteries and predominantly affects adults in their fifth decade. The "classic" systemic form of PAN typically involves multiple organ systems, most notably the renal, neurologic, and gastrointestinal systems, and has a male predominance. In contrast, the cutaneous-limited variant (cutaneous polyarteritis nodosa (c-PAN)) tends to affect women more frequently and, while generally confined to the skin and subcutaneous tissue, can still produce significant morbidity through painful subcutaneous nodules, livedo reticularis, and ulcerations [<xref rid="REF1" ref-type="bibr">1</xref>,<xref rid="REF2" ref-type="bibr">2</xref>].</p><p>The pathophysiology of systemic PAN often involves immune complex deposition, frequently associated with hepatitis B virus infection, leading to complement activation and endothelial damage. Conversely, in c-PAN, some studies have identified autoantibodies similar to those seen in antiphospholipid syndrome, suggesting distinct immunologic mechanisms [<xref rid="REF1" ref-type="bibr">1</xref>].</p><p>Given its relative rarity and an often-overlapping clinical spectrum with conditions such as livedoid vasculopathy or other medium-to-small vessel vasculitides, diagnosing c-PAN depends on a combination of thorough systemic evaluations and characteristic histopathologic findings [<xref rid="REF3" ref-type="bibr">3</xref>]. Herein, we report a chronic and successfully managed case of c-PAN in a middle-aged patient with metabolic comorbidities, highlighting the diagnostic considerations and therapeutic outcomes.</p></sec><sec sec-type="cases"><title>Case presentation</title><p>A 53-year-old married woman with a five-year history of type 2 diabetes and one year of hypertension presented with painful, progressively enlarging nodules and ulcerations on both lower legs. These lesions persisted for six months, intermittently healing and then recurring, leading to considerable discomfort and functional limitation. She reported occasional paresthesia in her feet, arthralgias, and two first-trimester miscarriages over a decade earlier, but no additional obstetric or gynecological issues.</p><p>Physical examination revealed multiple tender, round-to-irregular subcutaneous nodules that sometimes ulcerated, forming necrotic or hemorrhagic crusts, predominantly located in the perimalleolar region and the lower third of both legs. Livedo reticularis was noted, along with areas of hyperpigmentation (Figure <xref rid="FIG1" ref-type="fig">1</xref>).</p><fig position="anchor" fig-type="figure" id="FIG1"><label>Figure 1</label><caption><title>Perimalleolar ulcerations and branching livedoid pattern on the lower legs </title><p>Upper left panel showing the ulceration and livedo reticularis on the&#x000a0;external side of the right leg. Lower right panel showing a smaller ulceration and livedo reticularis on the medial side of the left ankle. Panel on the right showing branched livedo and ulceration of the external side of the left leg.</p></caption><graphic xlink:href="cureus-0017-00000082840-i01" position="float"/></fig><p>Laboratory tests demonstrated elevated inflammatory markers (erythrocyte sedimentation rate (ESR) up to 150 mm/h, C-reactive protein (CRP) at 45 mg/L), borderline high C3 with normal C4, and negative serologies for hepatitis B/C, HIV, parvovirus B19, ANCA, and cryoglobulins (Table <xref rid="TAB1" ref-type="table">1</xref>).</p><table-wrap position="float" id="TAB1"><label>Table 1</label><caption><title>The patient's laboratory test results </title><p>CRP: C-reactive protein; ESR: erythrocyte sedimentation rate</p></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Laboratory tests</td><td rowspan="1" colspan="1">Value</td><td rowspan="1" colspan="1">Reference range</td></tr><tr><td rowspan="1" colspan="1">C3</td><td rowspan="1" colspan="1">1.89 g/L (slightly elevated, indicating inflammation)</td><td rowspan="1" colspan="1">0.75 - 1.75 g/L</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">C4</td><td rowspan="1" colspan="1">0.38&#x000a0;g/L</td><td rowspan="1" colspan="1">0.2 - 0.5 g/L</td></tr><tr><td rowspan="1" colspan="1">ESR</td><td rowspan="1" colspan="1">150 mm/h (markedly elevated, indicating inflammation)</td><td rowspan="1" colspan="1">0-15 mm/hr</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">CRP</td><td rowspan="1" colspan="1">45 mg/L (markedly elevated, indicating inflammation)</td><td rowspan="1" colspan="1">10 mg/L</td></tr><tr><td rowspan="1" colspan="1">Hepatitis B serology</td><td rowspan="1" colspan="1">Negative (no significant level of detectable)</td><td rowspan="1" colspan="1">Negative</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Hepatitis C antibody</td><td rowspan="1" colspan="1">Negative (no significant level of detectable)</td><td rowspan="1" colspan="1">Negative</td></tr><tr><td rowspan="1" colspan="1">HIV serology</td><td rowspan="1" colspan="1">Negative (no significant level of detectable)</td><td rowspan="1" colspan="1">Negative</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">ANCA</td><td rowspan="1" colspan="1">Negative (no significant level of detectable)</td><td rowspan="1" colspan="1">&#x0003c; 20</td></tr><tr><td rowspan="1" colspan="1">Cryoglobulins</td><td rowspan="1" colspan="1">Negative (no significant level of detectable)</td><td rowspan="1" colspan="1">Negative</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Parvovirus B19&#x000a0;</td><td rowspan="1" colspan="1">Negative (no significant level of detectable)</td><td rowspan="1" colspan="1">&#x0003c; 0,9 IV</td></tr></tbody></table></table-wrap><p>Imaging studies (Doppler ultrasound, abdominal angioscan) showed no arterial stenosis, aneurysms, or visceral lesions (Figure <xref rid="FIG2" ref-type="fig">2</xref>).</p><fig position="anchor" fig-type="figure" id="FIG2"><label>Figure 2</label><caption><title>Abdominal angioscan </title><p>Sagittal (A) and coronal (B) angioscanner reconstruction showing good opacification of the abdominal aorta (red arrows), its various visceral branches, and the iliac arterial axes, with a normal caliber and parallel walls, with no atheromatous, inflammatory, or additive parietal thickening. Coronal reconstruction at portal time (C) of abdominal scanner showing no digestive parietal thickening or other visceral abnormality.</p><p>S: stomach; L: liver; C: colon; M: mesentery; Sp: spleen</p></caption><graphic xlink:href="cureus-0017-00000082840-i02" position="float"/></fig><p>A deep incisional biopsy at the edge of a representative ulcer confirmed necrotizing inflammation in medium-sized arterial walls with lobular panniculitis, consistent with c-PAN (Figure <xref rid="FIG3" ref-type="fig">3</xref>).</p><fig position="anchor" fig-type="figure" id="FIG3"><label>Figure 3</label><caption><title>Histologic image of the deep incisional biopsy taken at the edge of an ulcer</title><p>Left image showing inflammatory infiltrate around medium-caliber vessels with leukocytoclasis and fibrinoid necrosis, giving an &#x0201c;onion-bulb&#x0201d; appearance (black arrow, hematoxylin, eosin, and saffron (HES) &#x000d7;200). Image on the right of orcein staining highlighting the elastic fibers of an artery (orcein x200).</p></caption><graphic xlink:href="cureus-0017-00000082840-i03" position="float"/></fig><p>Electromyography indicated mild peripheral neuropathy, primarily attributed to her diabetes.</p><p>She began oral prednisone (0.5 mg/kg/day) and low-dose aspirin, later adding azathioprine as a steroid-sparing agent (200 mg/day). Daily wound care included debridement and dressing changes, which accelerated ulcer healing. Improvement in symptoms and noticeable wound healing were observed one month after treatment initiation. Over the ensuing months, prednisone was gradually tapered as lesions improved and discontinued by six months. Azathioprine was then reduced to 100 mg/day and completely stopped after one year without experiencing relapse or systemic progression (Figure <xref rid="FIG4" ref-type="fig">4</xref>).</p><fig position="anchor" fig-type="figure" id="FIG4"><label>Figure 4</label><caption><title>Post-treatment follow-up with disappearance of livedo and subcutaneous nodules and residual atrophic whitish scarring.</title><p>The left panel corresponds to the right lower leg&#x000a0;and the right panel represents the left lower leg.</p></caption><graphic xlink:href="cureus-0017-00000082840-i04" position="float"/></fig></sec><sec sec-type="discussion"><title>Discussion</title><p>c-PAN is a variant of PAN confined to the skin and subcutaneous tissues, sparing major organ systems in most cases [<xref rid="REF1" ref-type="bibr">1</xref>,<xref rid="REF4" ref-type="bibr">4</xref>]. Like systemic PAN, c-PAN is characterized by segmental necrotizing inflammation of medium-sized muscular arteries, which can lead to ischemia and infarction of the affected tissues. However, distinct from the classic systemic form, patients with c-PAN typically present with chronic or relapsing painful nodules, ulcerations, and livedo reticularis but lack systemic features such as significant renal, neurological, or gastrointestinal involvement [<xref rid="REF2" ref-type="bibr">2</xref>].&#x000a0;</p><p>Our patient&#x02019;s profile (middle-aged, female, with comorbidities (type 2 diabetes and hypertension)) added complexity to wound healing and heightened the initial suspicion for alternative diagnoses like livedoid vasculopathy or necrotic angiodermatitis. The main distinctive features of these differential diagnoses are discussed in Table <xref rid="TAB2" ref-type="table">2</xref>.</p><table-wrap position="float" id="TAB2"><label>Table 2</label><caption><title>Clinical, histopathological, and evolutive features of cutaneous polyarteritis nodosa (c-PAN), livedoid vasculopathy, and necrotic angiodermatitis. </title><p>Adapted from [<xref rid="REF5" ref-type="bibr">5</xref>-<xref rid="REF7" ref-type="bibr">7</xref>].</p></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">Cutaneous polyarteritis nodosa (c-PAN)</td><td rowspan="1" colspan="1">Livedoid vasculopathy</td><td rowspan="1" colspan="1">Necrotic angiodermatitis</td></tr><tr><td rowspan="1" colspan="1">Epidemiology</td><td rowspan="1" colspan="1">Women in the age group of 45 to 50 years old</td><td rowspan="1" colspan="1">Women who are 45 to 50 years old with a history of diabetes and arterial hypertension</td><td rowspan="1" colspan="1">Women in the age group of 50 to 70 years with cardiovascular comorbidities</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Common clinical presentation</td><td colspan="2" rowspan="1">Ramified livedo, purpura, necrosis, and ulceration with symmetrical involvement of the lower 1/3 of the legs, associated with white atrophy. No signs of venous insufficiency. No systemic involvement</td><td rowspan="1" colspan="1">Necrotic ulcer on the posterolateral legs.</td></tr><tr><td rowspan="1" colspan="1">Distinct clinical findings</td><td rowspan="1" colspan="1">Subcutaneous nodules along arterial vessels, and loco-regional peripheral neuropathy</td><td rowspan="1" colspan="1">Nociceptive pain</td><td rowspan="1" colspan="1">Ragged and purpuric margins, rapidly extensive, and associated with exquisite pain</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Histopathology</td><td rowspan="1" colspan="1">Segmental fibrinoid necrosis of medium-calibre arteries with perivascular neutrophilic infiltrate</td><td rowspan="1" colspan="1">Thrombosis of vessels in the superficial or middle dermis, with segmental hyalinization and lymphocytic perivascular infiltrate</td><td rowspan="1" colspan="1">Subcutaneous arteriosclerosis with hypertrophy of the media, thickening of the lamina, and intimal hyperplasia</td></tr><tr><td rowspan="1" colspan="1">Evolution</td><td colspan="2" rowspan="1">Chronic, relapsing-remitting course</td><td rowspan="1" colspan="1">Chronic, with no tendency to wound healing</td></tr></tbody></table></table-wrap><p>The negative ANCA in our patient, normal or only slightly altered complements, and absence of hepatic viral serologies also narrowed possibilities toward a vasculitis of medium-sized vessels rather than a small-vessel process. Finally, the&#x000a0;key element was the histopathologic confirmation showing fibrinoid necrosis and perivascular infiltrates in medium-sized arteries within the subcutaneous fat [<xref rid="REF2" ref-type="bibr">2</xref>, <xref rid="REF3" ref-type="bibr">3</xref>].&#x000a0;</p><p>Long-term management of c-PAN typically involves corticosteroids as first-line therapy, often in conjunction with steroid-sparing agents such as azathioprine or methotrexate [<xref rid="REF1" ref-type="bibr">1</xref>, <xref rid="REF3" ref-type="bibr">3</xref>, <xref rid="REF8" ref-type="bibr">8</xref>, <xref rid="REF9" ref-type="bibr">9</xref>]. This approach helps mitigate the side effects of prolonged high-dose steroid use. In our case, close follow-up ensured no systemic manifestations emerged, validating the diagnosis of a purely cutaneous-limited vasculitis. Recent studies have shown that remission and prevention of relapse can be achieved in many c-PAN cases if early, aggressive treatment is introduced, particularly in patients with comorbidities that might predispose them to worse outcomes [<xref rid="REF4" ref-type="bibr">4</xref>, <xref rid="REF10" ref-type="bibr">10</xref>].&#x000a0;</p><p>Although c-PAN is classically benign compared to systemic PAN, systemic evolution can occur in a small subset of patients, underscoring the need for routine monitoring, including laboratory screenings and clinical evaluations for evolving organ involvement [<xref rid="REF2" ref-type="bibr">2</xref>]. The patient in this report highlights how a diligent, multidisciplinary care model, encompassing dermatology, rheumatology, and endocrinology, can optimize results.&#x000a0;Key findings in our case include clinical presentation, absence of systemic involvement, histopathologic evidence, and favorable response to combined immunosuppressive and supportive therapies, with no relapse after gradual tapering.&#x000a0;</p><p>Clinically, her outcome underscores the importance of early recognition and the role of a combined therapeutic strategy for sustained remission. The case also reaffirms that metabolic and vascular risk factors (diabetes, hypertension) may complicate the clinical picture by delaying ulcer healing, demanding a holistic approach to optimize comorbidity management.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>c-PAN should be strongly considered in patients presenting with persistent, painful nodules and ulcerations confined to the lower extremities, particularly when small-vessel vasculitis and other vasculopathies have been excluded. Confirmatory biopsy, comprehensive systemic evaluation, and timely initiation of immunosuppressive therapy are crucial. This case illustrates the potential for complete remission and prevention of systemic progression with appropriate treatment and highlights the possibility of other differential diagnoses of chronic necrotic ulcerations of the lower legs in a middle-aged woman.</p></sec></body><back><fn-group content-type="conflict"><title>Disclosures</title><fn fn-type="COI-statement"><p><bold>Human subjects:</bold> Consent for treatment and open access publication was obtained or waived by all participants in this study.</p><p><bold>Conflicts of interest:</bold> In compliance with the ICMJE uniform disclosure form, all authors declare the following:</p><p><bold>Payment/services info:</bold> All authors have declared that no financial support was received from any organization for the submitted work.</p><p><bold>Financial relationships:</bold> All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.</p><p><bold>Other relationships:</bold> All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</p></fn></fn-group><fn-group content-type="other"><title>Author Contributions</title><fn fn-type="other"><p><bold>Concept and design:</bold>&#x000a0; Saadia Boughaleb, Hanane Baybay, FatimaZahra Mernissi</p><p><bold>Acquisition, analysis, or interpretation of data:</bold>&#x000a0; Saadia Boughaleb, Hanane Baybay, Imane Fadlallah, Layla Tahiri Elousrouti, FatimaZahra Mernissi</p><p><bold>Drafting of the manuscript:</bold>&#x000a0; Saadia Boughaleb</p><p><bold>Critical review of the manuscript for important intellectual content:</bold>&#x000a0; Saadia Boughaleb, Hanane Baybay, Imane Fadlallah, Layla Tahiri Elousrouti, FatimaZahra Mernissi</p><p><bold>Supervision:</bold>&#x000a0; Hanane Baybay, Imane Fadlallah, Layla Tahiri Elousrouti, FatimaZahra Mernissi</p></fn></fn-group><ref-list><title>References</title><ref id="REF1"><label>1</label><element-citation publication-type="journal"><article-title>High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa</article-title><source>Arthritis Rheum</source><person-group>
<name><surname>Kawakami</surname><given-names>T</given-names></name>
<name><surname>Yamazaki</surname><given-names>M</given-names></name>
<name><surname>Mizoguchi</surname><given-names>M</given-names></name>
<name><surname>Soma</surname><given-names>Y</given-names></name>
</person-group><fpage>1507</fpage><lpage>1513</lpage><volume>57</volume><year>2007</year><pub-id pub-id-type="pmid">18050170</pub-id>
</element-citation></ref><ref id="REF2"><label>2</label><element-citation publication-type="journal"><article-title>P&#x000e9;riart&#x000e9;rite noueuse: &#x000e9;tat de l&#x02019;art (Article in French)</article-title><source>Rev Rhum</source><person-group>
<name><surname>Pu&#x000e9;chal</surname><given-names>X</given-names></name>
</person-group><fpage>244</fpage><lpage>251</lpage><volume>89</volume><year>2022</year></element-citation></ref><ref id="REF3"><label>3</label><element-citation publication-type="journal"><article-title>Efficacy and safety of treatments in&#x000a0;cutaneous polyarteritis nodosa: a&#x000a0;French observational retrospective study</article-title><source>J Am Acad Dermatol</source><person-group>
<name><surname>Bettuzzi</surname><given-names>T</given-names></name>
<name><surname>Jachiet</surname><given-names>M</given-names></name>
<name><surname>Sbidian</surname><given-names>E</given-names></name>
<etal/>
</person-group><fpage>1035</fpage><lpage>1041</lpage><volume>86</volume><year>2022</year><pub-id pub-id-type="pmid">34224771</pub-id>
</element-citation></ref><ref id="REF4"><label>4</label><element-citation publication-type="journal"><article-title>Intravenous immunoglobulins for cutaneous polyarteritis nodosa resistant to conventional treatment</article-title><source>Scand J Rheumatol</source><person-group>
<name><surname>Breda</surname><given-names>L</given-names></name>
<name><surname>Franchini</surname><given-names>S</given-names></name>
<name><surname>Marzetti</surname><given-names>V</given-names></name>
<name><surname>Chiarelli</surname><given-names>F</given-names></name>
</person-group><fpage>169</fpage><lpage>170</lpage><volume>45</volume><year>2016</year><pub-id pub-id-type="pmid">26526030</pub-id>
</element-citation></ref><ref id="REF5"><label>5</label><element-citation publication-type="journal"><article-title>Recognition and management of cutaneous polyarteritis nodosum versus livedoid vasculitis: a case report</article-title><source>Cureus</source><person-group>
<name><surname>Forbes</surname><given-names>J</given-names></name>
<name><surname>Heydari</surname><given-names>M</given-names></name>
<name><surname>Kesselman</surname><given-names>MM</given-names></name>
<name><surname>Villacorta</surname><given-names>M</given-names></name>
</person-group><fpage>0</fpage><volume>12</volume><year>2020</year></element-citation></ref><ref id="REF6"><label>6</label><element-citation publication-type="journal"><article-title>Characteristics, risk factors and treatment reality in livedoid vasculopathy - a multicentre analysis</article-title><source>J Eur Acad Dermatol Venereol</source><person-group>
<name><surname>Weishaupt</surname><given-names>C</given-names></name>
<name><surname>Str&#x000f6;lin</surname><given-names>A</given-names></name>
<name><surname>Kahle</surname><given-names>B</given-names></name>
<etal/>
</person-group><fpage>1784</fpage><lpage>1791</lpage><volume>33</volume><year>2019</year><pub-id pub-id-type="pmid">31009111</pub-id>
</element-citation></ref><ref id="REF7"><label>7</label><element-citation publication-type="journal"><article-title>Curing necrotic angiodermatitis with an intact fish skin graft in a patient living with diabetes</article-title><source>Medicina (Kaunas)</source><person-group>
<name><surname>Dardari</surname><given-names>D</given-names></name>
<name><surname>Lequint</surname><given-names>C</given-names></name>
<name><surname>Jugnet</surname><given-names>AC</given-names></name>
<name><surname>B&#x000e9;nard</surname><given-names>T</given-names></name>
<name><surname>Bouly</surname><given-names>M</given-names></name>
<name><surname>Penfornis</surname><given-names>A</given-names></name>
</person-group><fpage>292</fpage><volume>58</volume><year>2022</year><pub-id pub-id-type="pmid">35208615</pub-id>
</element-citation></ref><ref id="REF8"><label>8</label><element-citation publication-type="journal"><article-title>Cutaneous polyarteritis nodosa diagnosis and treatment: a retrospective case series</article-title><source>J Am Acad Dermatol</source><person-group>
<name><surname>Stewart</surname><given-names>M</given-names></name>
<name><surname>Lo</surname><given-names>A</given-names></name>
<name><surname>Shojania</surname><given-names>K</given-names></name>
<name><surname>Au</surname><given-names>S</given-names></name>
<name><surname>Seidman</surname><given-names>MA</given-names></name>
<name><surname>Dutz</surname><given-names>JP</given-names></name>
<name><surname>Chan</surname><given-names>J</given-names></name>
</person-group><fpage>1370</fpage><lpage>1373</lpage><volume>87</volume><year>2022</year><pub-id pub-id-type="pmid">35714785</pub-id>
</element-citation></ref><ref id="REF9"><label>9</label><element-citation publication-type="journal"><article-title>Cutaneous polyarteritis nodosa: a report of 16 cases with clinical and histopathological analysis and a review of the published work</article-title><source>J Dermatol</source><person-group>
<name><surname>Ishiguro</surname><given-names>N</given-names></name>
<name><surname>Kawashima</surname><given-names>M</given-names></name>
</person-group><fpage>85</fpage><lpage>93</lpage><volume>37</volume><year>2010</year><pub-id pub-id-type="pmid">20175828</pub-id>
</element-citation></ref><ref id="REF10"><label>10</label><element-citation publication-type="journal"><article-title>Clinical and laboratory markers associated with relapse in cutaneous polyarteritis nodosa</article-title><source>JAMA Dermatol</source><person-group>
<name><surname>Kato</surname><given-names>A</given-names></name>
<name><surname>Hamada</surname><given-names>T</given-names></name>
<name><surname>Miyake</surname><given-names>T</given-names></name>
<name><surname>Morizane</surname><given-names>S</given-names></name>
<name><surname>Hirai</surname><given-names>Y</given-names></name>
<name><surname>Yamasaki</surname><given-names>O</given-names></name>
<name><surname>Iwatsuki</surname><given-names>K</given-names></name>
</person-group><fpage>922</fpage><lpage>926</lpage><volume>154</volume><year>2018</year><pub-id pub-id-type="pmid">29955757</pub-id>
</element-citation></ref></ref-list></back></article>